Package 55150-345-10

{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "6b48182a-4a21-4157-8efb-591ee87fb7d6", "openfda": {"upc": ["0355150345014"], "unii": ["F850569PQR"], "rxcui": ["1191250"], "spl_set_id": ["8bcf426a-b4fc-4f24-9ad0-fb26168a0b56"], "manufacturer_name": ["Eugia US LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 BOX (55150-345-01)  / 2 mL in 1 SYRINGE", "package_ndc": "55150-345-01", "marketing_start_date": "20210114"}, {"sample": false, "description": "10 SYRINGE in 1 BOX (55150-345-10)  / 2 mL in 1 SYRINGE", "package_ndc": "55150-345-10", "marketing_start_date": "20210114"}], "brand_name": "Naloxone Hydrochloride", "product_id": "55150-345_6b48182a-4a21-4157-8efb-591ee87fb7d6", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "55150-345", "generic_name": "Naloxone Hydrochloride", "labeler_name": "Eugia US LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Naloxone Hydrochloride", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": "1 mg/mL"}], "application_number": "ANDA213279", "marketing_category": "ANDA", "marketing_start_date": "20210114", "listing_expiration_date": "20261231"}